• Dr. Reddy’s Laboratories reported 9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended June (Q1FY23). On a year-on-year (YoY) basis, it witnessed a growth of 20%.
  • Its expenses for the quarter were down by 13% QoQ and up by 3% YoY.
  • The pharma major reported a net profit of Rs 1,189 crores in Q1FY23 as against a net profit of Rs 380 crores in Q1FY22.
  • The earnings per share (EPS) of Dr. Reddy’s Laboratories stood at 71.5 during Q1FY23..

Dr. Reddy’s Laboratories’ Financial Statements for Q1FY23:

(Rs, crores) Q1FY22 Q4FY22 Q1FY23 QoQ (%) YoY (%)
Total Income 5,053 5,597 6,087 9% 20%
Total Expenses 4,514 5,348 4,628 -13% 3%
Profit before tax 556 259 1,468 467% 164%
Tax 175 162 279 72% 59%
Profit after tax 380 97 1,189 1126% 213%
Earnings per share 23.0 5.8 71.5    

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results